147 related articles for article (PubMed ID: 38359473)
1. Establishment of induced pluripotent stem cell lines derived from Parkinson's disease Mexican patients: A sporadic (UNAMi002-A) and a familial (UNAMi003-A) case carrying a mutation in PINK1.
Flores-Ponce X; López-Ornelas A; Escobedo-Avila I; Rodríguez-Violante M; Dávila-Ortiz de Montellano D; Cervantes-Arriaga A; Monroy-Jaramillo N; Campos-Romo A; Velasco I
Stem Cell Res; 2024 Apr; 76():103337. PubMed ID: 38359473
[TBL] [Abstract][Full Text] [Related]
2. Generation of a human induced pluripotent stem cell line (UNAMi001-A) from a Mexican patient with sporadic Parkinson's disease.
Flores-Ponce X; López-Ornelas A; Escobedo-Avila I; Rodríguez-Violante M; Dávila-Ortiz de Montellano D; Cervantes-Arriaga A; Monroy-Jaramillo N; Velasco I
Stem Cell Res; 2022 Dec; 65():102972. PubMed ID: 36427474
[TBL] [Abstract][Full Text] [Related]
3. Generation of two human induced pluripotent stem cell lines from fibroblasts of Parkinson's disease patients carrying the ILE368ASN mutation in PINK1 (LCSBi002) and the R275W mutation in Parkin (LCSBI004).
Novak G; Finkbeiner S; Skibinski G; Bernini M; Donato C; Skupin A
Stem Cell Res; 2022 May; 61():102765. PubMed ID: 35378365
[TBL] [Abstract][Full Text] [Related]
4. Parkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and α-Synuclein Accumulation.
Chung SY; Kishinevsky S; Mazzulli JR; Graziotto J; Mrejeru A; Mosharov EV; Puspita L; Valiulahi P; Sulzer D; Milner TA; Taldone T; Krainc D; Studer L; Shim JW
Stem Cell Reports; 2016 Oct; 7(4):664-677. PubMed ID: 27641647
[TBL] [Abstract][Full Text] [Related]
5. Generation of an induced pluripotent stem cell line (GIBHi003-A) from a Parkinson's disease patient with mutant PINK1 (p. I368N).
Abdul MM; Ibañez DP; Zhao P; Liu H; Zhong X; Li Y; Zhang M; Li W; Li Y; Ward C; Chen S; Wang D; Qin B; Esteban MA; Wang X; Fan W; Luo Z
Stem Cell Res; 2019 Dec; 41():101607. PubMed ID: 31778937
[TBL] [Abstract][Full Text] [Related]
6. Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease.
Beevers JE; Caffrey TM; Wade-Martins R
Biochem Soc Trans; 2013 Dec; 41(6):1503-8. PubMed ID: 24256244
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease in a dish - Using stem cells as a molecular tool.
Badger JL; Cordero-Llana O; Hartfield EM; Wade-Martins R
Neuropharmacology; 2014 Jan; 76 Pt A():88-96. PubMed ID: 24035919
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of ghrelin receptors on dopaminergic neurons in the substantia nigra contributes to Parkinson's disease-like motor dysfunction.
Suda Y; Kuzumaki N; Sone T; Narita M; Tanaka K; Hamada Y; Iwasawa C; Shibasaki M; Maekawa A; Matsuo M; Akamatsu W; Hattori N; Okano H; Narita M
Mol Brain; 2018 Feb; 11(1):6. PubMed ID: 29458391
[TBL] [Abstract][Full Text] [Related]
9. Dissecting the non-neuronal cell contribution to Parkinson's disease pathogenesis using induced pluripotent stem cells.
Pons-Espinal M; Blasco-Agell L; Consiglio A
Cell Mol Life Sci; 2021 Mar; 78(5):2081-2094. PubMed ID: 33210214
[TBL] [Abstract][Full Text] [Related]
10. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.
Zuo L; Motherwell MS
Gene; 2013 Dec; 532(1):18-23. PubMed ID: 23954870
[TBL] [Abstract][Full Text] [Related]
11. The role of tyrosine hydroxylase-dopamine pathway in Parkinson's disease pathogenesis.
Zhou ZD; Saw WT; Ho PGH; Zhang ZW; Zeng L; Chang YY; Sun AXY; Ma DR; Wang HY; Zhou L; Lim KL; Tan EK
Cell Mol Life Sci; 2022 Nov; 79(12):599. PubMed ID: 36409355
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Parkinson's Disease through Personalized Medicine and Induced Pluripotent Stem Cells.
Stoddard-Bennett T; Reijo Pera R
Cells; 2019 Jan; 8(1):. PubMed ID: 30621042
[TBL] [Abstract][Full Text] [Related]
13. Alpha-synuclein dynamics in induced pluripotent stem cell-derived dopaminergic neurons from a Parkinson's disease patient (PARK4) with SNCA triplication.
Fukusumi H; Togo K; Sumida M; Nakamori M; Obika S; Baba K; Shofuda T; Ito D; Okano H; Mochizuki H; Kanemura Y
FEBS Open Bio; 2021 Feb; 11(2):354-366. PubMed ID: 33301617
[TBL] [Abstract][Full Text] [Related]
14. Cell-specific overexpression of COMT in dopaminergic neurons of Parkinson's disease.
Kuzumaki N; Suda Y; Iwasawa C; Narita M; Sone T; Watanabe M; Maekawa A; Matsumoto T; Akamatsu W; Igarashi K; Tamura H; Takeshima H; Tawfik VL; Ushijima T; Hattori N; Okano H; Narita M
Brain; 2019 Jun; 142(6):1675-1689. PubMed ID: 31135049
[TBL] [Abstract][Full Text] [Related]
15. Monitoring PINK1-Parkin Signaling Using Dopaminergic Neurons from iPS Cells.
Shiba-Fukushima K; Imai Y
Methods Mol Biol; 2021; 2322():81-92. PubMed ID: 34043195
[TBL] [Abstract][Full Text] [Related]
16. In search of early neuroradiological biomarkers for Parkinson's Disease: Alterations in resting state functional connectivity and gray matter microarchitecture in PINK1 -/- rats.
Cai X; Qiao J; Knox T; Iriah S; Kulkarni P; Madularu D; Morrison T; Waszczak B; Hartner JC; Ferris CF
Brain Res; 2019 Mar; 1706():58-67. PubMed ID: 30389398
[TBL] [Abstract][Full Text] [Related]
17. Generation of a human induced pluripotent stem cell line (CSC-40) from a Parkinson's disease patient with a PINK1 p.Q456X mutation.
Russ K; Marote A; Savchenko E; Collin A; Goldwurm S; Pomeshchik Y; Roybon L
Stem Cell Res; 2018 Mar; 27():61-64. PubMed ID: 29331938
[TBL] [Abstract][Full Text] [Related]
18. Parkinson's Disease-Associated Changes in the Expression of Neurotrophic Factors and their Receptors upon Neuronal Differentiation of Human Induced Pluripotent Stem Cells.
Novosadova EV; Nenasheva VV; Makarova IV; Dolotov OV; Inozemtseva LS; Arsenyeva EL; Chernyshenko SV; Sultanov RI; Illarioshkin SN; Grivennikov IA; Tarantul VZ
J Mol Neurosci; 2020 Apr; 70(4):514-521. PubMed ID: 31820346
[TBL] [Abstract][Full Text] [Related]
19. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
20. Modeling Parkinson's disease using induced pluripotent stem cells.
Byers B; Lee HL; Reijo Pera R
Curr Neurol Neurosci Rep; 2012 Jun; 12(3):237-42. PubMed ID: 22538490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
